BioSolar’s partner to manufacture & test commercial-grade Li-ion cells

By Nikita Chaurasia  Date: 2019-03-06

BioSolar’s partner to manufacture & test commercial-grade Li-ion cells
  • The company has successfully completed the initial phase of material preparation for developing full cell Li-ion prototype batteries.
  • The company’s technology partner would now be handling the building & testing portion of the program.

BioSolar, Inc., a Silicon Valley based energy storage technology and materials developer, has reportedly announced that it has completed the initial phase of material preparation for developing full cell Li-ion prototype batteries.

Supposedly, the company would now be collaborating with its South Korea based cell manufacturing partner to transition into the development and testing portion of the battery development program.

According to a press release by BioSolar Inc., the company’s Korean cell manufacturing partner has already commenced with the preparation procedures to produce the first batch of BioSolar commercial-grade Li-ion cylindrical cell prototype 21700. The first prototype batch would be tested to verify their key performance metrics in terms of cell energy capacity.

Following the successful production as well as testing of the first prototype batch, the company’s partner would be manufacturing additional prototype batches to verify other of the battery’s key performance metrics.

BioSolar believes that the innovative Lithium-ion cell design is capable of demonstrating commercial viability and attain increased exposure to the company’s customers, who could test the product and ultimately incorporate the additive technology into their businesses.

The CEO of BioSolar, Dr. David Lee stated that the company’s aim is to demonstrate the product’s technological feasibility along with its cost benefits to the customer. The company believes that the technology would enable higher energy and power capabilities, he said.

The firm’s eventual goal is to showcase that its additive technology could enhance and surpass performance objectives for its customers without having to disrupt their infrastructure and manufacturing processes while reducing costs, Dr. Lee added.

Reports suggest that the company has yet to unveil the financial information related to its Li-ion cell program collaboration with its Korean cell manufacturing partner.

About Author

Nikita Chaurasia     aeresearch.net

Nikita Chaurasia

An accomplished professional in the field of content development, playing with words comes naturally to Nikita Chaurasia. After completing her post-graduate MBA degree in Advertising and PR, Nikita worked across numerous content-driven verticals, undertaking diverse r...

Read More

More News By Nikita Chaurasia

TCS, Infosys, Accenture workforce to receive free Covid-19 vaccination

TCS, Infosys, Accenture workforce to receive free Covid-19 vaccination

By Nikita Chaurasia

Information technology giants Infosys, Accenture India, and Tata Consultancy Services will reportedly cover Covid-19 vaccination costs for their employees and their family, who are eligible and opt to receive the jab. This news comes along the heels...

Motorola Solutions to offer Norwegian Health Emergency Service with CRS

Motorola Solutions to offer Norwegian Health Emergency Service with CRS

By Nikita Chaurasia

Motorola Solutions has announced to have been selected by Helsetjenestens Driftsorganisasjon for Nødnett HF (HDO HF) to offer the Norwegian Health Emergency Service with a new CRS (Command Central Control Room Solution). Confirming the news,&...

Nestle India exploring options to directly sell products to consumers

Nestle India exploring options to directly sell products to consumers

By Nikita Chaurasia

Nestle India Ltd. is reportedly exploring their options of trying their hands at direct selling since consumers are largely turning towards the internet to purchase products ranging from staples to medicines amidst the COVID-19 pandemic. While the n...

Razorpay: New funding en route, meteoric rise in market value expected

Razorpay: New funding en route, meteoric rise in market value expected

By Nikita Chaurasia

Indian startup Razorpay is reportedly in discussions with Singapore-based sovereign wealth fund GIC Pvt. Ltd. and other existing investors to raise around USD 200 million in a funding round that would allow the fintech company to double its valuation...

FDA to allow pharma companies modify COVID-19 shots amid variants surge

FDA to allow pharma companies modify COVID-19 shots amid variants surge

By Nikita Chaurasia

With the rising cases of Coronavirus variants, the United States Food & Drug Administration (FDA) has reportedly introduced guidelines for pharmaceutical companies to modify their COVID-19 vaccine doses in an effort to curb the spread of the dise...